[1]
P. Gisondi, “[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]”, FE, vol. 26, no. 1, May 2025.